Särnstrand/Karlsson Clinical Consulting AB

Bengt Särnstrand, CEO
+46 709 13 12 39
bengt.sarnstrand@gmail.com

Särnstrand/Karlsson Clinical Consulting AB is a consulting company providing pre-clinical and clinical expertise to generate early and late development programs especially within the respiratory area.

Bengt Särnstrand has 40 years of experience from the pharmaceutical industry working as pharmacology researcher, team/department director, experimental medicine leader and clinical developing director in early as well as in mid stage projects within Draco/Astra/AstraZeneca. His area of expertise is in the translational phase between pre-clinical and clinical, “first time into human”, with different routes of administration, such as oral, IV and inhalation (nebulized, pMDIs and DPIs), as well as pharmacokinetic/pharmacodynamic and dose-finding studies in patients.

Kerstin Karlsson has a background as an intensive senior reg. nurse and 25+ years of experience from the pharmaceutical industry working as clinical trial monitor, clinical trial leader and group manager at a clinical operation department, including early to late and post market stage projects within Astra/AstraZeneca.

The company can provide clinical and strategic support in design of pre-clinical and clinical studies and programs, in conduction of studies as well as interpretation of studies.

Bengt Särnstrand has an associate professor position at Department of Matrix biology, Experimental Medical Science, Lund University.